Bausch + Lomb Corporation
$16.76
▼
-1.14%
2026-04-21 05:41:01
www.bausch.com
NYQ: BLCO
Explore Bausch + Lomb Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$5.94 B
Current Price
$16.76
52W High / Low
$18.91 / $10.45
Stock P/E
—
Book Value
$18.2
Dividend Yield
—
ROCE
1.55%
ROE
-5.39%
Face Value
—
EPS
$-1.02
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
13,000
Beta
0.65
Debt / Equity
80.46
Current Ratio
1.55
Quick Ratio
1.04
Forward P/E
15.4
Price / Sales
1.15
Enterprise Value
$10.78 B
EV / EBITDA
17.69
EV / Revenue
2.11
Rating
Hold
Target Price
$18.35
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ICU Medical, Inc. | $130.58 | 4,461.76 | $3.27 B | — | 3.08% | 0.04% | $160.29 / $107 | $86.03 |
| 2. | Ekso Bionics Holdings, Inc. | $11.38 | — | $40.55 M | — | -116.13% | -1.08% | $13.5 / $2.73 | $2.54 |
| 3. | STAAR Surgical Company | $25.53 | — | $1.27 B | — | -11.99% | -21.7% | $30.81 / $15.59 | $6.97 |
| 4. | Femasys Inc. | $0.42 | — | $25.6 M | — | -460.52% | -4.56% | $1.29 / $0.31 | $0.1 |
| 5. | Solventum Corporation | $69.51 | 7.83 | $12.08 B | — | 5.66% | 38.86% | $88.2 / $62.38 | $29.1 |
| 6. | Retractable Technologies, Inc. | $0.65 | — | $19.46 M | 1.18% | -10.73% | -15.56% | $1.14 / $0.62 | $2.48 |
| 7. | Teleflex Incorporated | $131.95 | — | $5.84 B | 1.03% | 4.14% | 1.58% | $138.93 / $100.18 | $70.7 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 1.41 B | 1.28 B | 1.28 B | 1.14 B | 1.28 B |
| Operating Profit | 158 M | 80 M | 11 M | -61 M | 86 M |
| Net Profit | -58 M | -28 M | -62 M | -212 M | -3 M |
| EPS in Rs | -0.16 | -0.08 | -0.17 | -0.6 | -0.01 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 5.1 B | 4.79 B | 4.15 B | 3.77 B |
| Operating Profit | 188 M | 206 M | 204 M | 220 M |
| Net Profit | -360 M | -317 M | -260 M | 6 M |
| EPS in Rs | -1.02 | -0.89 | -0.73 | 0.02 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 14.02 B | 13.47 B | 13.44 B | 11.14 B |
| Total Liabilities | 7.5 B | 6.92 B | 6.52 B | 4.04 B |
| Equity | 6.45 B | 6.47 B | 6.85 B | 7.03 B |
| Current Assets | 2.98 B | 2.79 B | 2.74 B | 2.14 B |
| Current Liabilities | 1.92 B | 1.74 B | 1.58 B | 1.3 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 283 M | 232 M | -17 M | 345 M |
| Investing CF | -455 M | -412 M | -2.11 B | -215 M |
| Financing CF | 225 M | 178 M | 2.08 B | 81 M |
| Free CF | -66 M | -59 M | -198 M | 170 M |
| Capex | -349 M | -291 M | -181 M | -175 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 15.56% | 10.03% | — | — |
| Earnings Growth % | -21.92% | -4433.33% | — | — |
| Profit Margin % | -6.62% | -6.27% | 0.16% | — |
| Operating Margin % | 4.3% | 4.92% | 5.84% | — |
| Gross Margin % | 60.93% | 60.4% | 59.69% | — |
| EBITDA Margin % | 12.54% | 12.04% | 15.87% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.